Kim, E. Y., Kim, A., Lee, G., Lee, H., & Chang, Y. S. (2018). Different mutational characteristics of the subsets of EGFR-tyrosine kinase inhibitor sensitizing mutation-positive lung adenocarcinoma. BMC Cancer.
शिकागो स्टाइल उद्धरणKim, Eun Young, Arum Kim, Gaeun Lee, Hangsuck Lee, और Yoon Soo Chang. "Different Mutational Characteristics of the Subsets of EGFR-tyrosine Kinase Inhibitor Sensitizing Mutation-positive Lung Adenocarcinoma." BMC Cancer 2018.
एमएलए उद्धरणKim, Eun Young, et al. "Different Mutational Characteristics of the Subsets of EGFR-tyrosine Kinase Inhibitor Sensitizing Mutation-positive Lung Adenocarcinoma." BMC Cancer 2018.
चेतावनी: ये उद्धरण हमेशा 100% सटीक नहीं हो सकते हैं.